2012-10-06 19:02:41 - Fast Market Research recommends "Constipation - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Constipation - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Constipation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Constipation. Constipation - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot

of the global therapeutic scenario for Constipation.
* A review of the Constipation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Constipation pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468390_constipation_pipeline_review_h2_2012. ..


Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Constipation.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Constipation pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Constipation Overview
Therapeutics Development
An Overview of Pipeline Products for Constipation
Constipation Therapeutics under Development by Companies
Constipation Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Constipation Therapeutics - Products under Development by Companies
Constipation Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Constipation Therapeutics Development
Dainippon Sumitomo Pharma Co., Ltd.
Dong-A Pharmaceutical Co., Ltd.
Shire Plc
ARYx Therapeutics
Yuhan Corporation
Theravance, Inc.
Sucampo Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc.
Braintree Laboratories, Inc.
Ferring Pharmaceuticals, Inc.
Ardelyx, Inc.
MicroDose Therapeutx, Inc.
Beech Tree Labs, Inc.
Constipation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
naronapride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
prucalopride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
linaclotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
linaclotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lubiprostone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MDT-006 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
velusetrag - Drug Profile
Product Description
Mechanism of Action
R&D Progress
plecanatide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
mosapride citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chenodeoxycholic acid sodium salt - Drug Profile
Product Description
Mechanism of Action
R&D Progress
YKP-10811 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
pyridostigmine bromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
elobixibat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Neostigmine + Glycopyrrolate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
methylnaltrexone bromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
methylnaltrexone bromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
escitalopram oxalate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Chronic Constipation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DA-6886 - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468390&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.